| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 01/12/2011 | EP2272513A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2272512A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2271373A2 99mtc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical |
| 01/12/2011 | EP2271372A1 Imaging agents |
| 01/12/2011 | CN1675245B Monoclonal antibody hPAM4 |
| 01/12/2011 | CN101940797A Cladded nuclide labeled protein microsphere, preparation method and applications thereof |
| 01/12/2011 | CN101486734B 99Tcm(CO)3 ciprofloxacin dithiocarbamate complexes, as well as preparation method and application |
| 01/11/2011 | US7867475 Using NK gene complex family of type II oligomeric signal transmitting receptor proteins containing C-type lectin-binding domain; increasing tumor necrosis factor alpha production; autoimmune diseases |
| 01/11/2011 | US7867171 Management of gastro-intestinal disorders |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/06/2011 | WO2011002096A1 Labeling compound for pet |
| 01/06/2011 | WO2010127054A3 Imaging tumor perfusion, and oxidative metabolism using dynamic ace pet in patients with head and neck cancer during radiotherapy |
| 01/06/2011 | WO2010111303A3 Imaging agents for detecting neurological disorders |
| 01/06/2011 | WO2010028216A3 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 01/06/2011 | US20110003710 Selectin ligands useful in the diagnosis and treatment of cancer |
| 01/06/2011 | US20110002915 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002850 Nitro-Imidazole Hypoxia Imaging Agent |
| 01/06/2011 | US20110002849 Therapy selection method |
| 01/06/2011 | US20110002848 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 01/06/2011 | US20110002847 Method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate |
| 01/06/2011 | US20110002846 Cd24 as a brain tumor stem cell marker and a diagnostic and therapeutic target in primary neural and glial tumors of the brain |
| 01/06/2011 | US20110002845 Methods of treating, diagnosing or detecting fgf21-associated disorders |
| 01/06/2011 | US20110002844 Stabilization of macromolecular membranes |
| 01/06/2011 | US20110002843 Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm |
| 01/05/2011 | EP2268317A2 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 01/05/2011 | EP1485415B1 Neoplasm specific antibodies and uses thereof |
| 01/05/2011 | EP1401467B1 Alpha-fetoprotein peptides and uses thereof |
| 01/05/2011 | CN1878562B Antibody therapy |
| 01/05/2011 | CN101555232B Pyridazinone compound marked by fluorine-18, preparation method and applications |
| 01/04/2011 | US7863413 Peptide protein translation inhibitor and the use thereof for protein translation control |
| 01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/04/2011 | US7862828 Allergy vaccines containing hybrid polypeptides |
| 01/04/2011 | US7862813 Multivalent immunoglobulin polypeptide for treatment of immune system abnormalities |
| 01/04/2011 | US7862798 Vitamin-targeted imaging agents |
| 01/04/2011 | US7862605 Coated implantable medical device |
| 01/04/2011 | CA2449054C Integrin targeting liposome for nucleic acid delivery |
| 01/04/2011 | CA2317505C Enzyme catalyzed therapeutic agents |
| 01/04/2011 | CA2303338C Water soluble paclitaxel derivatives |
| 01/04/2011 | CA2281272C 2-amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives and a process for preparation thereof |
| 12/30/2010 | US20100331815 Transluminal delivery of oncoltyic viruses for cancer therapy |
| 12/30/2010 | US20100331676 Gamma probe detection of amyloid plaque using radiolabeled a-beta binding compounds |
| 12/30/2010 | US20100329979 Method and Composition to Evaluate Cytochrome P450 2D6 Isoenzyme Activity Using a Breath Test |
| 12/30/2010 | US20100329978 Highly selective sigma receptor ligands |
| 12/30/2010 | US20100329977 Method for imaging tumor tissue |
| 12/29/2010 | WO2010129572A3 Pet radiotracers for imaging fatty acid metablolism and storage |
| 12/29/2010 | WO2010119389A3 Pretargeting kit, method and agents used therein |
| 12/29/2010 | EP2267445A1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject |
| 12/29/2010 | EP2266954A1 Novel bifunctional chelating compounds containing hydroxamic acid residues |
| 12/29/2010 | EP2266953A1 Novel bifunctional chelating compounds containing hydroxamic acid residues |
| 12/29/2010 | EP2266629A1 Reagents and methods for radiolabelling of RGD-containing peptides. |
| 12/29/2010 | EP2022792B1 Novel compound having affinity to amyloid |
| 12/29/2010 | CN101928327A Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes |
| 12/29/2010 | CN101927009A Specific sentinel lymph node developer drug and preparation method thereof |
| 12/29/2010 | CN101927008A Diagnostic and therapeutic gastric cancer vascular specific binding peptide GEBP11 isotope probe |
| 12/29/2010 | CN101927007A Method for imaging tumor tissue |
| 12/28/2010 | US7858088 chimeric anti-EGP-2-binding scFv fragment 4D5MOC-A; for treatment of human carcinomas; Pseudomonas exotoxin A |
| 12/28/2010 | US7858070 fusion propteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications |
| 12/23/2010 | WO2010148177A2 Compounds, compositions, methods of synthesis, and methods of treatment |
| 12/23/2010 | WO2010148163A1 Radiation enhanced macromolecular delivery of therapeutic agents for chemotherapy |
| 12/23/2010 | WO2010146722A1 Method and system for concentrating radioactive technetium as raw material for radioactive drug and labeling compound therefor and collecting the same by elution |
| 12/23/2010 | US20100324319 Tame based chelators and uses thereof |
| 12/23/2010 | US20100322857 Radiolabelled peptide based compounds and uses thereof |
| 12/23/2010 | US20100322856 Compositions and Methods for Inducing Angiogenesis |
| 12/23/2010 | US20100322855 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using |
| 12/23/2010 | US20100322854 Positron emission tomography imaging method |
| 12/23/2010 | US20100322851 KID3 and KID3 Antibodies That Bind Thereto |
| 12/23/2010 | US20100322850 New plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells |
| 12/23/2010 | US20100322849 Enhanced b cell cytotoxicity of cdim binding antibody |
| 12/22/2010 | EP2264070A1 Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-CD20 antibody |
| 12/22/2010 | EP2264018A2 Thioflavin derivatives for use in the diagnosis of Alzheimer's disease |
| 12/22/2010 | EP2263693A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 12/22/2010 | EP2262542A2 Apparatus and method for preparing medicines containing radioactive substances |
| 12/22/2010 | EP1536843B1 Radiolabeled compounds and liposomes and their methods of making and using the same |
| 12/22/2010 | CN101925367A Targeted radiotherapy |
| 12/22/2010 | CN101921295A Technetium carbonyl marked 2-nitroimidazole complex as well as preparation method and application thereof |
| 12/22/2010 | CN101921279A Spirocyclic heterocyclic derivatives and methods of their use |
| 12/22/2010 | CN101921263A 2-metridazloe derivative as well as application and preparation method thereof |
| 12/22/2010 | CN101921164A Synthesis of (1)-beta-elemene, (-)-beta-elemenal, (-)-beta-elemenol, (-)-beta-elemene fluoride and their analogues, intermediates, and composition and uses thereof |
| 12/22/2010 | CN101920024A Brain targeted liposome preparation of <99m>Tc tumor imaging medicament and application thereof |
| 12/22/2010 | CN101423535B <99m>TcN(DGDTC)2 complexes as well as preparation method and use thereof |
| 12/22/2010 | CN101336114B Radiolabelling method using polymers |
| 12/21/2010 | US7855175 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production; anemia; genetic discorder; blood disorders; erythropoietin receptor agonists |
| 12/21/2010 | US7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 12/21/2010 | US7854920 Bioavailability, nontoxic; 2-(3'-Iodo-4'-aminophenyl)-6-methoxybenzothiazole |
| 12/21/2010 | US7854919 Multivalent constructs for therapeutic and diagnostic applications |
| 12/21/2010 | US7854918 Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 12/21/2010 | CA2618466C Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 12/16/2010 | WO2010144846A2 Gastrointestinal disease or disorder imaging and treatment |
| 12/16/2010 | WO2010144788A2 Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer stem cells |
| 12/16/2010 | WO2010142754A2 Pet imaging of fibrogenesis |
| 12/16/2010 | WO2010079079A3 PDGF-Rβ BINDERS |
| 12/16/2010 | WO2010076654A3 Cysteine-free technetium (tc) or rhenium (re) chelating peptide tags and their use |
| 12/16/2010 | US20100316567 Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer stem cells |
| 12/16/2010 | US20100316566 Radiolabeled hedgehog derivatives for imaging and therapy |
| 12/16/2010 | US20100316565 Novel imaging method |
| 12/16/2010 | US20100316564 Immunological targeting of pathological tau proteins |
| 12/16/2010 | US20100316563 Method For The Preparation Of New Oligoclonal Antibodies |
| 12/16/2010 | CA2763824A1 Pet imaging of fibrogenesis |
| 12/15/2010 | EP2260875A2 Folate-receptor targeted imaging agents |
| 12/15/2010 | EP2260866A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |